|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||0.0067 - 0.0084|
|52 Week Range||0.0003 - 0.0200|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Sandusky, Ohio--(Newsfile Corp. - April 13, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today released a management update on the company's ongoing CBD Pharmaceutical Development Program. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled, "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE ...
PAO Group, Inc. (USOTC: PAOG) today released a management update on the company's ongoing CBD Pharmaceutical Development Program.
Dallas, Texas--(Newsfile Corp. - April 12, 2021) - Puration, Inc. (OTC Pink: PURA) today announced a management update scheduled April 20th, 2021 to follow the upcoming FY2021 Annual Report coming later this week.The update will highlight PURA's commitment to striking on an opportunity to increase its ownership in Alkame Holdings, Inc. above its recently acquired %5 interest.The PURA management update will provide even more thorough details on the Farmersville groundbreaking planned for this summer ...